NCT00614120 Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00614055 Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00613951 Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00611884 Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00605475 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00598793 Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy Status COMPLETED Phase PHASE3
NCT00592969 Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00577590 Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM Status COMPLETED Phase NA
NCT00575588 52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period Status COMPLETED Phase PHASE3
NCT00571519 Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus Status TERMINATED Phase PHASE3
NCT00568984 Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00562172 Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study) Status COMPLETED Phase PHASE4
NCT00560690 The Effect of Adding Metformin to the Treatment of Hepatitis C Status COMPLETED Phase PHASE4
NCT00546728 The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes Status COMPLETED Phase PHASE4
NCT00544518 Impact of Benfluorex Versus Metformin on Glucose Control and Insulin Secretion in Chinese Type 2 Diabetic Patients Status UNKNOWN Phase PHASE2
NCT00528879 A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone Status COMPLETED Phase PHASE3
NCT00528372 A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise Status COMPLETED Phase PHASE3